Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain
February 19, 2019 — Pfizer Inc. (NYSE: PFE) and Eli Lilly and Company (NYSE: LLY) today announced positive top-line results
Launchpad: Five New Spring Hair Releases
As the prestige hair category continues to boom — up 23 percent for the 12-month period ended in January, to
Late fatherhood is fraught with risks for both mother and child
Not only the age of the mother for the course of a pregnancy is crucial. New research shows that the
56 million children could die by 2030 from preventable causes
From preventable causes such as malnutrition and lack of health care, a media could die, according to a report by
Faster come to the doctor: What is the new law?
To get to a specialist appointment for NHS patients is often not so easy and it’s frustrating. While you may
How PDA Boosts Your Connection with Bae
“Kiss me,” Brandon whispered in my ear, his hands cupping my face while Dave Matthews crooned, “You’ve got your ball/You’ve
Tetanus-treatment costs more than $ 800,000
A six-year-old is suffering from the disease in the United States of Tetanus, after his parents had refused vaccinations. For
Gene behind long-recognized mitochondrial disease has highly varied effects
For more than two decades, mutations in a gene located in the DNA of mitochondria have been classified as a